Tianjin Chasesun Pharmaceutical Co., LTD
Quick facts
Phase 2 pipeline
- 16mg，KB
KB is a small molecule drug that targets the mechanism of action of the drug.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: